Patients should discuss risks carefully if they have: A history of pancreatitis Severe nausea, vomiting, or gastroparesis Gallbladder disease Severe dehydration risk Advanced kidney disease with frequent vomiting or poor oral intake A personal or family history of medullary thyroid cancer Multiple endocrine neoplasia syndrome type 2 Pregnancy, plans for pregnancy, or breastfeeding Also, if you have active lupus nephritis or unstable lupus, your rheumatologist and nephrologist should be involved before starting any new medicine that could affect hydration, nutrition, kidney function, or medication tolerance
What is the expected demand growth for GLP-1 Receptor Agonists in the global market between 2026 and 2036
Guilln-Lozoya had no disclosures
Pharmacodynamic Drug Interactions (of High Clinical Significance) Warfarin: Interaction: ALC may potentiate warfarins anticoagulant effects Mechanism: Unclear
In Module 1, the sample subset members referred to the CPT code 14301 - Adjacent tissue transfer or rearrangement, any area